On the other hand, less than 1% of gliomas harbor IDH2 hotspot mutations, mostly occurring at arginine 172 (IDH2R172H mutation) or arginine 140 (IDH2R140 mutation) [19]. The gene discussed is IDH2; the disease is central nervous system cancer.